{"indice": 749, "titulo": "Vacinas contra a COVID-19 - OPAS/OMS | Organiza\u00c3\u00a7\u00c3\u00a3o Pan-Americana da Sa\u00c3\u00bade", "url": "https://google.com/url?q=https://www.paho.org/pt/vacinas-contra-covid-19&sa=U&ved=2ahUKEwiU3IHbw-HzAhUOrJUCHUT5AnMQ0gJ6BAgAEAQ&usg=AOvVaw31perWyzDKK703-KOuzRw6", "texto": "\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Vacinas contra a COVID-19 - OPAS/OMS | Organiza\u00c3\u00a7\u00c3\u00a3o Pan-Americana da Sa\u00c3\u00bade \n \n \n \n \n \n \n \n \n \n \n \n \n \n      Pular para o conte\u00c3\u00bado principal\n     \n \n \n \n \n \n \n User account menu \n \n \n Entrar \n \n \n \n \n English Espa\u00c3\u00b1ol Portugu\u00c3\u00aas Fran\u00c3\u00a7ais \n \n \n \n              Idioma  \n \n \n \n \n \n \n \n \n \n \n \n \n In\u00c3\u00adcio T\u00c3\u00b3picos Pa\u00c3\u00adses Recursos Publica\u00c3\u00a7\u00c3\u00b5es Dados Ferramentas Biblioteca Virtual em Sa\u00c3\u00bade Campus Virtual de Sa\u00c3\u00bade P\u00c3\u00bablica Rastreamento de embarques da OPAS Fundo Rotat\u00c3\u00b3rio Iniciativas Migra\u00c3\u00a7\u00c3\u00a3o e sa\u00c3\u00bade nas Am\u00c3\u00a9ricas HEARTS nas Am\u00c3\u00a9ricas Alertas e  atualiza\u00c3\u00a7\u00c3\u00b5es  epidemiol\u00c3\u00b3gicas Not\u00c3\u00adcias Recursos para jornalistas Comunicados de imprensa Not\u00c3\u00adcias do pa\u00c3\u00ads Not\u00c3\u00adcias das Unidades T\u00c3\u00a9cnicas Notas da web Eventos Campe\u00c3\u00b5es da sa\u00c3\u00bade Hist\u00c3\u00b3rias Her\u00c3\u00b3is da Sa\u00c3\u00bade P\u00c3\u00bablica Colaboradores Materiais de comunica\u00c3\u00a7\u00c3\u00a3o Brochures Infogr\u00c3\u00a1ficos Campanhas Campanhas passadas Sobre a About PAHO/WHO Hist\u00c3\u00b3ria da OPAS Declara\u00c3\u00a7\u00c3\u00a3o de contribui\u00c3\u00a7\u00c3\u00b5es fixas devidas pelos Estados Membro O que fazemos \u00c3\u0093rg\u00c3\u00a3os Diretores Confer\u00c3\u00aancia Sanit\u00c3\u00a1ria Pan-Americana Conselho Diretor O Comit\u00c3\u00aa Executivo Subcomit\u00c3\u00aa de Programa, Or\u00c3\u00a7amento e Administra\u00c3\u00a7\u00c3\u00a3o \n \n \n \n \n \n Buscar \n Buscar \n \n \n \n \n \n \n \n \n   \n \n \u00c2\u00a0 \n FUNDO COVID-19\u00e2\u0080\u0094DOE AGORA! \n \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n In\u00c3\u00adcio \n \n \n                  Vacinas contra a COVID-19\n               \n \n \n Vacinas contra a COVID-19 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \u00a0 \n \n \n \n \n Esta p\u00c3\u00a1gina centraliza recursos voltados aos governos para a\u00a0introdu\u00c3\u00a7\u00c3\u00a3o e implanta\u00c3\u00a7\u00c3\u00a3o bem-sucedida das vacinas contra a COVID-19, bem como recursos para que o p\u00c3\u00bablico em geral possa obter respostas \u00c3\u00a0s perguntas relacionadas \u00c3\u00a0s vacinas. \n \n \n \n \n \u00a0 \n \n \n \n \n \n \u00a0 \n \n \n \n \n OPAS: Imuniza\u00c3\u00a7\u00c3\u00a3o \n \n \n \n \n OPAS: Fundo Rotat\u00c3\u00b3rio \n \n \n \n \n OMS: Vacinas contra a COVID-19 \n \n \n \n \n \u00a0 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Recursos \n \n \n \n \n \n   \n \n OPAS: Grupo T\u00c3\u00a9cnico Assessor (GTA) em doen\u00c3\u00a7as imunopreven\u00c3\u00adveis - Documentos sobre vacinas contra a COVID-19 \n \n \n \n \n   \n \n Recursos das m\u00c3\u00addias sociais \n \n\u00c2\u00a0 \n \n \n \n \n   \n \n Kit de ferramentas\u00c2\u00a0 \n\u00c2\u00a0 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n   \n \n \n \n \n \n \u00c2\u00a0 \n \n \n \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n Cobertura da vacina\u00c3\u00a7\u00c3\u00a0o contra COVID-19 nas Am\u00c3\u00a9ricas \n \n \n Painel com dados sobre a vacina COVID-19 aplicada na Regi\u00c3\u00a3o das Am\u00c3\u00a9ricas. \n \n \n \n \n \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n Farmacovigil\u00c3\u00a2ncia para vacinas COVID-19 \n \n \n O objetivo deste painel \u00c3\u00a9 apoiar os processos regulamentares para a introdu\u00c3\u00a7\u00c3\u00a3o e o monitoramento da seguran\u00c3\u00a7a das vacinas COVID-19.  \n \n \n \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n REVELAC-I para vacinas COVID-19 \n \n \n O objetivo da rede \u00c3\u00a9 estimar a efic\u00c3\u00a1cia das vacinas COVID-19 na preven\u00c3\u00a7\u00c3\u00a3o de hospitaliza\u00c3\u00a7\u00c3\u00b5es relacionadas ao IRAG. \n \n \n \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n Panorama das vacinas candidatas contra a COVID-19 \n \n \n Este documento compila informa\u00c3\u00a7\u00c3\u00b5es atualizadas sobre os diversos candidatos \u00c3\u00a0 vacina COVID-19.  \n \n \n \n \n \n \n \n \n \n \n Vacina\u00c3\u00a7\u00c3\u00a3o contra a COVID-19 nas Am\u00c3\u00a9ricas - Kit de ferramentas  \n \n \n \n :: Recomenda\u00c3\u00a7\u00c3\u00b5es do Grupo T\u00c3\u00a9cnico Assessor (GTA) \n \n \n \n \n Sexta reuni\u00c3\u00a3o ad hoc do Grupo T\u00c3\u00a9cnico Assessor (GTA) da OPAS em Doen\u00c3\u00a7as Imunopreven\u00c3\u00adveis. EUA, 16 de novembro de 2020 (reuni\u00c3\u00a3o virtual \n Quinta reuni\u00c3\u00a3o ad hoc do Grupo T\u00c3\u00a9cnico Assessor (GTA) em Doen\u00c3\u00a7as Imunopreven\u00c3\u00adveis. EUA, 4 de agosto de 2020 (reuni\u00c3\u00a3o virtual) \n \n \n \n \n \n \n \n ::\u00c2\u00a0 Plano Nacional de Implementa\u00c3\u00a7\u00c3\u00a3o e Vacina\u00c3\u00a7\u00c3\u00a3o (NDVP) \n \n \n \n \n Orienta\u00c3\u00a7\u00c3\u00a3o para planejamento nacional de implementa\u00c3\u00a7\u00c3\u00a3o e vacina\u00c3\u00a7\u00c3\u00a3o para vacinas contra a COVID-19 \n Orienta\u00c3\u00a7\u00c3\u00b5es sobre a elabora\u00c3\u00a7\u00c3\u00a3o de um plano nacional de implementa\u00c3\u00a7\u00c3\u00a3o e vacina\u00c3\u00a7\u00c3\u00a3o para vacinas contra a COVID-19 \n Ferramenta de Avalia\u00c3\u00a7\u00c3\u00a3o de Prontid\u00c3\u00a3o para Vacinas contra a COVID-19 (VIRAT) \n Diretrizes para planejamento da introdu\u00c3\u00a7\u00c3\u00a3o de vacinas contra a COVID-19, vers\u00c3\u00a3o: julho de 2020 \n \n \n \n \n \n \n ::\u00c2\u00a0 Microplanejamento e prioriza\u00c3\u00a7\u00c3\u00a3o de popula\u00c3\u00a7\u00c3\u00b5es  \n \n \n \n \n Introdu\u00c3\u00a7\u00c3\u00a3o da vacina contra a COVID-19: Orienta\u00c3\u00a7\u00c3\u00b5es para determinar os grupos priorit\u00c3\u00a1rios e elaborar o microplanejamento. Vers\u00c3\u00a3o 1, 18 de janeiro de 2021 \n \n \n \n \n \n \n \n ::\u00c2\u00a0 Suprimento e log\u00c3\u00adstica \n \n \n \n \n Vacina\u00c3\u00a7\u00c3\u00a3o contra a COVID-19: orienta\u00c3\u00a7\u00c3\u00b5es sobre suprimento e log\u00c3\u00adstica: orienta\u00c3\u00a7\u00c3\u00b5es provis\u00c3\u00b3rias, 12 de fevereiro de 2021 \n \n \n \n \n \n \n \n \n ::\u00c2\u00a0 Seguran\u00c3\u00a7a vacinal \n \n \n \n \n Orienta\u00c3\u00a7\u00c3\u00b5es para Implementa\u00c3\u00a7\u00c3\u00a3o do Sistema Regional de Vigil\u00c3\u00a2ncia de EAPV/EAIE para Vacinas Contra a COVID-19 \n Comunica\u00c3\u00a7\u00c3\u00a3o em crises relacionadas \u00c3\u00a0 seguran\u00c3\u00a7a vacinal: Orienta\u00c3\u00a7\u00c3\u00a3o T\u00c3\u00a9cnica \n Como se comunicar sobre a seguran\u00c3\u00a7a das vacinas: Diretrizes para orientar os trabalhadores da sa\u00c3\u00bade quanto \u00c3\u00a0 comunica\u00c3\u00a7\u00c3\u00a3o com pais, m\u00c3\u00a3es, cuidadores e pacientes \n \n \n \n \n \n \n \n \n ::\u00c2\u00a0 Dados e monitoramento \n \n \n \n \n Monitoramento da vacina\u00c3\u00a7\u00c3\u00a3o contra a COVID-19: Considera\u00c3\u00a7\u00c3\u00b5es para a coleta e uso de dados de vacina\u00c3\u00a7\u00c3\u00a3o \n \n \n \n \n \n \n \n \n ::\u00c2\u00a0 Avalia\u00c3\u00a7\u00c3\u00a3o da introdu\u00c3\u00a7\u00c3\u00a3o de vacinas contra a COVID-19 \n \n \n \n \n Avalia\u00c3\u00a7\u00c3\u00a3o de efetividade das vacinas contra a COVID-19. Orienta\u00c3\u00a7\u00c3\u00a3o Provis\u00c3\u00b3ria. 17 de mar\u00c3\u00a7o de 2021  \n Calculadora del tama\u00c3\u00b1o de la muestra para la evaluaci\u00c3\u00b3n de la eficacia de la vacuna COVID-19 \n \n \n \n \n \n \n \n \n ::\u00c2\u00a0 Capacita\u00c3\u00a7\u00c3\u00a3o \n \n \n \n \n Lista de treinamentos relacionados a vacinas contra a COVID-19 \n Vacina contra a COVID-19: Lista de verifica\u00c3\u00a7\u00c3\u00a3o \n Forma\u00c3\u00a7\u00c3\u00a3o dos trabalhadores da sa\u00c3\u00bade para a vacina\u00c3\u00a7\u00c3\u00a3o contra a COVID-19 \n Fluxograma: Comunica\u00c3\u00a7\u00c3\u00a3o pelos profissionais de de sa\u00c3\u00bade durante vacina\u00c3\u00a7\u00c3\u00a3o contra a COVID-19 \n Orienta\u00c3\u00a7\u00c3\u00a3o para planejamento nacional de implementa\u00c3\u00a7\u00c3\u00a3o e vacina\u00c3\u00a7\u00c3\u00a3o para vacinas contra a COVID-19 \n Vacina contra a COVID-19: Folheto informativo para pacientes \n Guia de uso para profissionais de sa\u00c3\u00bade: Triagem, esclarecimento e obten\u00c3\u00a7\u00c3\u00a3o do consentimento para vacina\u00c3\u00a7\u00c3\u00a3o contra a COVID-19 \n Perguntas frequentes sobre vacinas contra a COVID-19 para profissionais de sa\u00c3\u00bade \n \n \n \n \n \n \n \n \n ::\u00c2\u00a0 Comunica\u00c3\u00a7\u00c3\u00a3o de risco, envolvimento da comunidade e demanda \n \n \n \n \n Guia para formular uma estrat\u00c3\u00a9gia de comunica\u00c3\u00a7\u00c3\u00a3o de riscos com rela\u00c3\u00a7\u00c3\u00a3o \u00c3\u00a0s vacinas contra a COVID-19: Um recurso para os pa\u00c3\u00adses das Am\u00c3\u00a9ricas \n Necessidades, percep\u00c3\u00a7\u00c3\u00b5es e demandas da comunidade: ferramenta de avalia\u00c3\u00a7\u00c3\u00a3o da comunidade \n Realiza\u00c3\u00a7\u00c3\u00a3o de atividades de envolvimento da comunidade para vacinas contra a COVID-19: Orienta\u00c3\u00a7\u00c3\u00a3o provis\u00c3\u00b3riae \n Dados para a a\u00c3\u00a7\u00c3\u00a3o: como alcan\u00c3\u00a7ar altos n\u00c3\u00adveis de capta\u00c3\u00a7\u00c3\u00a3o das vacinas contra a COVID-19: Orienta\u00c3\u00a7\u00c3\u00a3o provis\u00c3\u00b3ria \n Aceita\u00c3\u00a7\u00c3\u00a3o e demanda de vacinas contra a COVID-19: Orienta\u00c3\u00a7\u00c3\u00a3o provis\u00c3\u00b3ria \n Aceita\u00c3\u00a7\u00c3\u00a3o e demanda de vacinas contra a COVID-19: modelo de plano de comunica\u00c3\u00a7\u00c3\u00a3o \n Recurso de parceiro: Guia de campo do UNICEF para gest\u00c3\u00a3o de desinforma\u00c3\u00a7\u00c3\u00a3o sobre vacinas \n Comunica\u00c3\u00a7\u00c3\u00a3o em crises relacionadas \u00c3\u00a0 seguran\u00c3\u00a7a vacinal: Orienta\u00c3\u00a7\u00c3\u00a3o T\u00c3\u00a9cnica \n Como se comunicar sobre a seguran\u00c3\u00a7a das vacinas: Diretrizes para orientar os trabalhadores da sa\u00c3\u00bade quanto \u00c3\u00a0 comunica\u00c3\u00a7\u00c3\u00a3o com pais, m\u00c3\u00a3es, cuidadores e pacientes \n Fluxograma: Comunica\u00c3\u00a7\u00c3\u00a3o pelos profissionais de de sa\u00c3\u00bade durante vacina\u00c3\u00a7\u00c3\u00a3o contra a COVID-19 \n \n \n \n \n \n \n \n \n ::\u00c2\u00a0 Recursos para vacinas espec\u00c3\u00adficas  \n \n \n \n \n Vacina da Janssen (Ad26.COV2.S COVID-19): Orienta\u00c3\u00a7\u00c3\u00a3o provis\u00c3\u00b3ria e mais recursos \n Vacina da AstraZeneca/Oxford: Recomenda\u00c3\u00a7\u00c3\u00b5es provis\u00c3\u00b3rias e mais informa\u00c3\u00a7\u00c3\u00b5es \n Vacina da Moderna (mRNA-1273): Recomenda\u00c3\u00a7\u00c3\u00b5es provis\u00c3\u00b3rias e mais informa\u00c3\u00a7\u00c3\u00b5es \n Vacina da Pfizer\u00e2\u0080\u0093BioNTech: Recomenda\u00c3\u00a7\u00c3\u00b5es provis\u00c3\u00b3rias e mais informa\u00c3\u00a7\u00c3\u00b5es \n Vacina da Sinopharm: Recomenda\u00c3\u00a7\u00c3\u00b5es provis\u00c3\u00b3rias e mais informa\u00c3\u00a7\u00c3\u00b5es\u00c2\u00a0 \n \n \n \n \n \n \n \n \n ::\u00c2\u00a0 Perguntas frequentes \n \n \n \n \n Documento T\u00c3\u00a9cnico: Perguntas frequentes sobre as vacinas candidatas contra a COVID-19 e os mecanismos de acesso a elas \n Para o p\u00c3\u00bablico em geral: Perguntas frequentes sobre vacinas contra a COVID-19 \n Dez coisas que os profissionais de sa\u00c3\u00bade precisam saber sobre as vacinas contra a COVID-19 \n Enfrentando mitos sobre as vacinas contra a COVID-19 \n \n Kit da OMS para vacina\u00c3\u00a7\u00c3\u00a3o contra a COVID-19 \n \n \n \n \n \n \n \n \n \n Vacina contra a COVID-19: Recomenda\u00c3\u00a7\u00c3\u00b5es provis\u00c3\u00b3rias e mais informa\u00c3\u00a7\u00c3\u00b5es \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n Pfizer\u00e2\u0080\u0093BioNTech\u00c2\u00a0 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n Moderna \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n AstraZeneca \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n Janssen \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n Sinopharm \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n   \n \n \n \n \n \n \n \n \n Sinovac \n \n \n \n \n \n \n \n \n \n \n \n \n V\u00c3\u00addeos \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Link para a lista de v\u00c3\u00addeos sobre vacinas e COVID-19 \n \n \n \n \n \n \n \n \n \n \n \n \n \n Not\u00c3\u00adcia \n \n \n \n \n \n   \n \n OPAS alerta que apenas uma em cada quatro pessoas na Am\u00c3\u00a9rica Latina e no Caribe foi totalmente vacinada contra COVID-19 1 set 2021 \n \n \n \n \n   \n \n OPAS lan\u00c3\u00a7a nova plataforma colaborativa para impulsionar a produ\u00c3\u00a7\u00c3\u00a3o regional de vacinas contra a COVID-19 25 ago 2021 \n \n \n \n \n   \n \n OPAS come\u00c3\u00a7ar\u00c3\u00a1 a adquirir vacinas contra a COVID-19 para ampliar seu acesso na Am\u00c3\u00a9rica Latina e no Caribe 11 ago 2021 \n \n \n \n \n   \n \n Controle da COVID-19 nas Am\u00c3\u00a9ricas levar\u00c3\u00a1 anos se vacina\u00c3\u00a7\u00c3\u00a3o continuar em ritmo lento, afirma diretora da OPAS 9 jun 2021 \n \n \n \n \n \n \n \n \n \n \n \n MAIS \n \n \n \n \n \n \n Hist\u00c3\u00b3rias \n \n \n \n \n \n   \n \n Munic\u00c3\u00adpio brasileiro de Aracaju protege popula\u00c3\u00a7\u00c3\u00a3o em situa\u00c3\u00a7\u00c3\u00a3o de rua com vacina contra COVID-19 27 ago 2021 \n \n \n \n \n \n \n \n \n \n \n \n Eventos \n \n \n \n \n \n   \n \n Webinar sobre aceita\u00c3\u00a7\u00c3\u00a3o e capta\u00c3\u00a7\u00c3\u00a3o de vacinas no contexto da seguran\u00c3\u00a7a vacinal e outras quest\u00c3\u00b5es 19 abr 2021 \n \n \n \n \n \n \n \n Ver Eventos \n \n \n \n \n Documentos t\u00c3\u00a9cnicos e cient\u00c3\u00adficos \n \n \n \n \n \n   \n 10 ago 2021 Declara\u00c3\u00a7\u00c3\u00a3o provis\u00c3\u00b3ria sobre estrat\u00c3\u00a9gias de fracionamento de doses de vacinas contra a COVID-19 \n \n \n \n   \n 10 ago 2021 Declara\u00c3\u00a7\u00c3\u00a3o provis\u00c3\u00b3ria sobre doses de refor\u00c3\u00a7o das vacinas contra a COVID-19 \n \n \n \n \n   \n 10 ago 2021 Declara\u00c3\u00a7\u00c3\u00a3o provis\u00c3\u00b3ria sobre vacina\u00c3\u00a7\u00c3\u00a3o heter\u00c3\u00b3loga contra a COVID-19 \n \n \n \n   \n 21 jul 2021 Perguntas frequentes sobre vacinas contra COVID-19. Vers\u00c3\u00a3o 5. 20 de julho de 2021 \n \n \n \n \n \n \n \n \n \n \n \n MAIS \n \n \n Veja todos os documentos \n \n \n \n \n Materiais de comunica\u00c3\u00a7\u00c3\u00a3o \n \n \n \n \n \n \n \n \n \n \n 3 set 2021 Passos cruciais para o armazenamento, distribui\u00c3\u00a7\u00c3\u00a3o e manejo de vacinas que requerem temperaturas ultrabaixas \n \n \n \n   \n 21 jul 2021 Perguntas frequentes sobre vacinas contra COVID-19. Vers\u00c3\u00a3o 5. 20 de julho de 2021 \n \n \n \n \n   \n 8 jul 2021 Desinforma\u00c3\u00a7\u00c3\u00a3o vacinas COVID-19 - Cole\u00c3\u00a7\u00c3\u00a3o de redes sociais  \n \n \n \n   \n 8 jul 2021 Mitos e verdades vacinas COVID-19 - Cole\u00c3\u00a7\u00c3\u00a3o de redes sociais \n \n \n \n \n \n \n \n \n \n \n \n MAIS \n \n \n Veja todos os documentos \n \n \n \n \n \n \n \n \n Mapa do site \n \n \n Sobre a OPAS/OMS \n \n \n \n \n Ajuda e servi\u00c3\u00a7os \n \n \n Notifica\u00c3\u00a7\u00c3\u00a3o de privacidade \n \n \n Rela\u00c3\u00a7\u00c3\u00b5es comerciais com a OPAS \n \n \n Sistema de Gest\u00c3\u00a3o de Integridade e Conflitos (SGAIC) \n \n \n Termos e condi\u00c3\u00a7\u00c3\u00b5es de uso do site  \n \n \n \n \n Recursos \n \n \n Centros Colaboradores \n \n \n Biblioteca Virtual em Sa\u00c3\u00bade \n \n \n Campus virtual de sa\u00c3\u00bade p\u00c3\u00bablica \n \n \n Biblioteca Digital da OPAS (IRIS) \n \n \n Dados \n \n \n \n \n Siga-nos \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Escrit\u00c3\u00b3rio Regional para as Am\u00c3\u00a9ricas da Organiza\u00c3\u00a7\u00c3\u00a3o Mundial da Sa\u00c3\u00bade \n Representa\u00c3\u00a7\u00c3\u00a3o da OPAS e da OMS no Brasil \nSetor de Embaixadas Norte, Lote 19 - Bras\u00c3\u00adlia, Distrito Federal, Brasil CEP: 70800-400\u00a0 \nContato: + 55 61 3251-9595/ geral@paho.org \n \u00c2\u00a9 Organiza\u00c3\u00a7\u00c3\u00a3o Pan-Americana da Sa\u00c3\u00bade. Todos os direitos reservados. \n \n \n \n \n \n \n \n \n \n \n \n \n \n", "encoding": "utf-8"}